Articles dans des revues avec comité de lecture (159)
  1. 121. Achachi, A., Florins, A., Gillet, N., Debacq, C., Urbain, P., Foutsop, G. M., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., Lagneaux, L., Burny, A., Kettmann, R., & Willems, L. (2005). Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102(29), 10309-10314. doi:10.1073/pnas.0504248102
  2. 122. Tondreau, T., Lagneaux, L., Dejeneffe, M., Massy, M., Mortier, C., Delforge, A., & Bron, D. (2004). Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation, 72(7), 319-326. doi:10.1111/j.1432-0436.2004.07207003.x
  3. 123. Dumon, J. C., Journé, F., Kheddoumi, N., Lagneaux, L., & Body, J.-J. (2004). Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells. European urology, 45(4), 521-8; discussion 528-9. doi:10.1016/j.eururo.2003.12.012
  4. 124. Lewalle, P., Delforge, A., Aoun, M., Crombez, P., De Wilde, V., Theunissen, K., Lagneaux, L., Nowak, B., Misplon, V., Bron, D., & Martiat, P. (2004). Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management. Blood cells, molecules, & diseases, 33(3), 256-260. doi:10.1016/j.bcmd.2004.08.012
  5. 125. Tondreau, T., Lagneaux, L., Dejeneffe, M., Delforge, A., Massy, M., Mortier, C., & Bron, D. (2004). Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy, 6(4), 372-379. doi:10.1080/14653240410004943
  6. 126. Lagneaux, L., de Meulenaer, E. C., Delforge, A., Dejeneffe, M., Massy, M., Moerman, C., Hannecart, B., Canivet, Y., Lepeltier, M. F., & Bron, D. (2003). Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Experimental hematology, 30(11), 1293-1301. doi:10.1016/S0301-472X(02)00920-7
  7. 127. Snoeck, R., Andrei, G., Bodaghi, B., Lagneaux, L., Daelemans, D., de Clercq, E., Neyts, J., Schols, D., Naesens, L., Michelson, S., Bron, D., Otto, M. J., Bousseau, A., Nemecek, C., & Roy, C. (2002). 2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Antiviral research, 55(3), 413-424. doi:10.1016/S0166-3542(02)00074-8
  8. 128. Bron, D., De Bruyn, C., Lagneaux, L., Tondreau, T., & Delforge, A. (2002). Les cellules souches hématopoiétiques: sources, indications et perspectives. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 157(1-2), 135-45; discussion 145-6.
  9. 129. Lagneaux, L., Delforge, A., Dejeneffe, M., Massy, M., Bernier, M., & Bron, D. (2002). Hydroxychloriquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of Bcl-2/bax/ratio. Leukemia & lymphoma, 43(5), 1087-1095.
  10. 130. Lagneaux, L., Delforge, A., Carlier, S., Massy, M., Bernier, M., & Bron, D. (2001). Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors. British journal of haematology, 112(2), 344-352. doi:10.1046/j.1365-2141.2001.02553.x
  11. 131. Lagneaux, L., Delforge, A., Dejeneffe, M., Massy, M., Hannecart, B., Canivet, Y., Lepeltier, M. F., de Meulenaer, E. C., & Bron, D. (2001). Rapid induction of apoptosis in human myeloid leukemic cells as a result of sonochemical effects generated by low energy ultrasonics: A promising tool. Blood, 98(11 PART I), 556a.
  12. 132. Fromigue, O., Lagneaux, L., & Body, J.-J. (2000). Bisphosphonates induce breast cancer cell death in vitro. Journal of bone and mineral research, 15(11), 2211-2221. doi:10.1359/jbmr.2000.15.11.2211
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>